This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
author：A harvest day for lazy cats
This wave of surge, someone has fallen behind...
In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals, and the proportion of shares held in pharmaceuticals has not increased, and pharmaceuticals are also net sellers in October. In terms of breakdown, innovative drugs and CXOs performed better in October, with fund managers Zhang Wei, Cui Chenlong, and Hao Miao outperforming Hong Kong innovative drug ETFs. The internal differentiation of medicine is also relatively serious, with medical ETFs and medical device ETFs performing poorly, while funds are concerned about Hong Kong stock pharmaceutical ETFs. Among active funds, Zhang Wei, Guanglei and Hao Miao outperformed the Hong Kong stock innovative drug ETF, and Cui Chenlong's independently managed fund rose 9.08% in October. Fund managers such as Xiao Shiyuan and Chi Chensen have also increased their allocations in innovative drugs and vaccine-related fields.
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
This wave of surge, someone has fallen behind... In the third quarter, the public offering significantly increased its position in medicine, and in October, medicine rose in response. However, foreign investors have different attitudes towards pharmaceuticals and the proportion of shares held in pharmaceuticals
The burden of proving causation is a matter of great concern in medical litigation in Germany, and due to the complexity and professionalism of medical acts, it is often difficult for patients to prove that medical acts are related to damages.
The National Health Commission reminds to prevent the risk of drug shortage, and the classification and definition of medical devices will be further standardized...... Finishing|Atian 01 Sanming Medical Reform New Trends: Specialized...
With the deepening of medical reform, the baton of "national tertiary hospital performance appraisal" of public hospitals, the reform of medical insurance payment methods, the adjustment of income structure of public hospitals, discipline construction, infrastructure...
